Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AVDL - Avadel Pharmaceuticals: Looking Good For Investors And Patients With Narcolepsy

AVDL - Avadel Pharmaceuticals: Looking Good For Investors And Patients With Narcolepsy

Avadel Pharmaceuticals plc
  • Avadel's flagship compound, FT218, is on its way towards approval with the FDA.
  • FT218 once nightly dose has been proven more efficient and better accepted by patients than competing products.
  • Potential obstacle towards approval seen as minimal risk.
  • Narcolepsy is an over-$1 billion market annually in the U.S. alone.

For further details see:

Avadel Pharmaceuticals: Looking Good For Investors And Patients With Narcolepsy
Stock Information
Company Name: Avadel Pharmaceuticals plc
Stock Symbol: AVDL
Market: NASDAQ
Website: avadel.com
Menu
AVDL AVDL Quote AVDL Short AVDL News AVDL Articles AVDL Message Board
Get AVDL Alerts

News, Short Squeeze, Breakout and More Instantly...